The prevalence and major determinants of non-compliance with anti-seizure medication among children

Ladan Afsharkhas1, Shabnam Zamani1, Azita Tavasoli1

  • 1Department of Pediatric Neurology, Hazrat-e Ali Asghar Hospital, Iran University of Medical Sciences, Tehran, Iran.

PubMed

Insights

Adherence to anti-seizure medications in children with epilepsy is low, around 41.7%. Factors like parental education and seizure type significantly impact adherence, with parental forgetfulness being a common barrier.

Area of Science:

  • Pediatrics
  • Neurology
  • Pharmacology

Background:

  • Variable adherence to anti-seizure medications (ASMs) is observed in pediatric epilepsy.
  • Limited data exists on ASM adherence and associated factors in the Iranian pediatric population.

Purpose of the Study:

  • To determine the frequency of adherence to ASMs in children with epilepsy.
  • To identify factors influencing ASM adherence in this population.

Main Methods:

  • A cross-sectional study involving 120 children with epilepsy at Ali Asghar Hospital, Tehran, Iran (2019-2020).
  • Demographic data and ASM adherence were assessed using the Modified Morisky Scale (MMS).

Main Results:

  • Overall ASM adherence was 41.7%.
  • Higher adherence was noted in children with educated parents.
  • Lower adherence was associated with perinatal morbidities and specific seizure types (e.g., atonic seizures).
  • Common reasons for non-adherence included perceived treatment ineffectiveness, parental forgetfulness, and issues during travel.

Conclusions:

  • Parental education, seizure type, and perinatal morbidity are significant predictors of ASM non-adherence in children.
  • Targeted interventions addressing these factors are crucial for improving treatment compliance.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
314
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
373
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
414
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
592